ArticleLipids in health and disease2026
Mental health-related quality of life is associated with sustained lipid-lowering therapy adherence after acute coronary syndrome.
Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAcute coronary syndrome (ACS) is a critical manifestation of cardiovascular disease, which necessitates rigorous secondary prevention to reduce recurrent events and mortality. While lipid-lowering therapy (LLT) is integral to post-ACS secondary prevention, long-term adherence remains a significant clinical challenge. This study evaluated psychological, socioeconomic, and clinical factors associated with LLT adherence in patients after ACS, with a specific focus on mental health components and chronic comorbidities.
methodsACS survivors were included from the Transitions, Risks, and Actions in Coronary Events-Center for Outcomes Research and Education cohort (TRACE-CORE). Baseline demographic, medical history and mental health data - including the 36-Item Short Form Survey (SF-36) Mental Component (MCS) and Physical Component Scores (PCS) and the Patient Health Questionnaire-9 (PHQ-9)- were collected during hospitalization. Adherence to LLT was assessed up to twelve-months post-discharge. We performed a comparative analysis between patients with complete versus incomplete follow-up and utilized binary logistic regression to identify factors associated with adherence to LLT.
resultsOf the cohort, 51% completed the 12-month follow-up. Completers were significantly older, had higher education, better mental health metrics (higher MCS, lower PHQ-9), and higher prevalence of chronic conditions including diabetes, hypertension, and hyperlipidemia. Participants in the adherent group were more likely to be males and White and had higher MCS and PCS scores. Lower income (<$35,000) was associated with adherence in unadjusted analyses but did not remain independently associated after multivariable adjustment. In the regression, each 10-point increase in MCS (OR 1.24; 95% CI 1.07-1.44), hyperlipidemia (OR 1.42;1.05-1.92), male sex (OR 1.36;1.02-1.81) and white race (1.47;1.02-2.13) were associated with increased odds of adherence.
conclusionsMental health-related quality of life, as measured by MCS, along with hyperlipidemia, male sex, and White race, was associated with LLT adherence after ACS. These findings suggest that post-ACS secondary prevention may benefit from incorporating patient-reported mental health assessment to identify individuals at increased risk for nonadherence.
Indexed as
Identifiers
42482230What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.